IS7775A - DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru - Google Patents

DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru

Info

Publication number
IS7775A
IS7775A IS7775A IS7775A IS7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A IS 7775 A IS7775 A IS 7775A
Authority
IS
Iceland
Prior art keywords
viral
transcribes
unmodified
dna vaccine
proteins
Prior art date
Application number
IS7775A
Other languages
English (en)
Inventor
Wayne Gough Gerald
Michael Roberts Christopher
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS7775A publication Critical patent/IS7775A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS7775A 2002-10-03 2005-03-29 DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru IS7775A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222953.2A GB0222953D0 (en) 2002-10-03 2002-10-03 Novel Compounds
PCT/EP2003/011158 WO2004031222A2 (en) 2002-10-03 2003-10-01 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus

Publications (1)

Publication Number Publication Date
IS7775A true IS7775A (is) 2005-03-29

Family

ID=9945247

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7775A IS7775A (is) 2002-10-03 2005-03-29 DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru

Country Status (21)

Country Link
US (2) US20060165713A1 (is)
EP (1) EP1546191A2 (is)
JP (1) JP2006516386A (is)
KR (1) KR20050050115A (is)
CN (1) CN100393878C (is)
AR (1) AR041515A1 (is)
AU (1) AU2003294672A1 (is)
BR (1) BR0314986A (is)
CA (1) CA2500093A1 (is)
CO (1) CO5580837A2 (is)
GB (1) GB0222953D0 (is)
IS (1) IS7775A (is)
MA (1) MA27474A1 (is)
MX (1) MXPA05003558A (is)
NO (1) NO20051561L (is)
NZ (1) NZ539154A (is)
PL (1) PL376534A1 (is)
RU (1) RU2354701C2 (is)
TW (1) TW200411055A (is)
WO (1) WO2004031222A2 (is)
ZA (1) ZA200503201B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540098A (en) 2002-10-29 2008-09-26 Coley Pharmaceutical Group Ltd Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
CL2008000249A1 (es) * 2007-01-30 2008-05-30 Transgene Sa Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
GB0710538D0 (en) * 2007-06-01 2007-07-11 Glaxo Group Ltd Vaccine
WO2011161244A1 (en) * 2010-06-25 2011-12-29 Vaccibody As Homodimeric protein constructs
CA2965498A1 (en) * 2014-10-24 2016-04-28 Hpvvax, Llc. Compositions and uses of a papilloma virus (hpv) vaccine for the treatment of hpv related cancer and skin lesions
JP2019505512A (ja) 2016-01-08 2019-02-28 バッシボディ アクスイェ セルスカプ 治療用抗癌ネオエピトープワクチン
CA3023022A1 (en) * 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
WO2021205027A1 (en) 2020-04-09 2021-10-14 Vaccibody As Individualized therapeutic anticancer vaccine
CA3197920A1 (en) * 2020-11-25 2022-06-02 Douglas E. Brough Human papilloma virus vaccines and uses of the same for hpv associated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
NZ523683A (en) * 2000-07-21 2004-08-27 Glaxo Group Ltd Codon-optimized papilloma virus sequences

Also Published As

Publication number Publication date
WO2004031222A2 (en) 2004-04-15
RU2005109155A (ru) 2006-03-10
NZ539154A (en) 2007-05-31
KR20050050115A (ko) 2005-05-27
CO5580837A2 (es) 2005-11-30
CA2500093A1 (en) 2004-04-15
AR041515A1 (es) 2005-05-18
ZA200503201B (en) 2006-06-28
CN1720261A (zh) 2006-01-11
JP2006516386A (ja) 2006-07-06
MA27474A1 (fr) 2005-08-01
TW200411055A (en) 2004-07-01
AU2003294672A1 (en) 2004-04-23
US20070264283A1 (en) 2007-11-15
CN100393878C (zh) 2008-06-11
RU2354701C2 (ru) 2009-05-10
EP1546191A2 (en) 2005-06-29
NO20051561L (no) 2005-06-02
GB0222953D0 (en) 2002-11-13
US20060165713A1 (en) 2006-07-27
WO2004031222A3 (en) 2004-08-19
BR0314986A (pt) 2005-08-09
NO20051561D0 (no) 2005-03-23
PL376534A1 (pl) 2006-01-09
MXPA05003558A (es) 2005-06-03

Similar Documents

Publication Publication Date Title
NO20044326D0 (no) Virale antigener
EP1773403A4 (en) VIRAL ADJUVANZIA
ITBS20030077A1 (it) Pinza pneumatica angolare.
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
IL182562A0 (en) Improved viral purification methods
NO20053892D0 (no) Virale polymeraseinhibitorer
NO20040888L (no) Innleggsdel for gripeapparat.
BR0318327B1 (pt) garra cirérgica.
IL164551A0 (en) Improved viral purification methods
EP1718608A4 (en) INHIBITORS OF VIRAL POLYMERASE
DE60329983D1 (de) Wachsestersynthase-dna-sequenz, protein und verwendungen davon
GB0206359D0 (en) Viral antigens
ATA19522003A (de) Gag-bindungsproteine
NO20052149D0 (no) Vaksine.
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
DE502005007723D1 (de) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone,
ITBS20030049A1 (it) Struttura di pinza pneumatica angolare.
NL1026716A1 (nl) Verbindingen.
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
ATE437656T1 (de) Impfstoff gegen das maul- und klauensäure-virus
NO20051561D0 (no) Vaksine
EP1539938A4 (en) CHIMERIC GB-VIRUS B (GBV-B)
ITRM20030493A0 (it) Ranghinatore.
DE10358553B8 (de) Zange, insbesondere Ösenzange
ES1056663Y (es) Abrazadera.